EBITDA: Income before interest, taxes, depreciation and amortization.
Pulse Biosciences, Inc (PLSE) had EBITDA of $-42.37M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-42.21M |
|
-- |
|
-- |
|
$43.57M |
|
$-43.57M |
|
$1.36M |
|
$-42.21M |
|
$-42.21M |
|
$-42.21M |
|
$-42.21M |
|
$-42.21M |
|
$-42.21M |
|
$-43.57M |
|
|
EBITDA |
$-42.37M |
48.04M |
|
48.04M |
|
$-0.88 |
|
$-0.88 |
|
| Balance Sheet Financials | |
$45.33M |
|
$1.53M |
|
$13.83M |
|
$59.15M |
|
$6.71M |
|
-- |
|
$8.09M |
|
$14.79M |
|
$44.36M |
|
$39.68M |
|
$44.36M |
|
55.14M |
|
| Cash Flow Statement Financials | |
$-33.04M |
|
$-0.12M |
|
$16.39M |
|
$61.14M |
|
$44.37M |
|
$-16.77M |
|
$7.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-33.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-95.15% |
|
-106.37% |
|
-71.36% |
|
-95.15% |
|
$0.80 |
|
$-0.69 |
|
$-0.69 |
|